Speckle-tracking strain imaging, particularly Global Longitudinal Strain (GLS), has evolved from a research measure into a routine clinical necessity. Whether assessing subclinical cardiotoxicity in oncology, monitoring early heart failure, or evaluating complex valvular disease, myocardial deformation metrics provide insight into cardiac function that traditional Ejection Fraction (EF) cannot match. Even with strong clinical evidence and clear guideline support, many echocar

Toronto, Ontario – December 18, 2024 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce Ventripoint and ASCEND Cardiovascular, a leading provider of cardiovascular IT solutions, have signed a term sheet defining the general terms and conditions for a non-exclusive license to Ventripoint’s VMS+ proprietary technology. The two parties expect to execute the license agreement within 30 days. ASCEND Cardiovascular has ov

Enterprise Imaging has become a cornerstone for many healthcare organizations seeking to streamline the collection, storage, and management of comprehensive medical imaging records. For good reason – this approach offers significant efficiencies, ensuring that imaging data is accessible and consolidated across various departments.​ However, the intricate nature of cardiology presents unique challenges that general Enterprise Imaging solutions often fail to address. Cardiolog

Toronto, Ontario – December 18, 2024 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce Ventripoint and ASCEND Cardiovascular, a leading provider of cardiovascular IT solutions, have signed a term sheet defining the general terms and conditions for a non-exclusive license to Ventripoint’s VMS+ proprietary technology. The two parties expect to execute the license agreement within 30 days. ASCEND Cardiovascular has ov